| Literature DB >> 27222835 |
Aghil Sharifzadeh1, Hojjatollah Shokri2.
Abstract
OBJECTIVE: The purpose of this study was to assay the antifungal activity of selected essential oils obtained from plants against both fluconazole (FLU)-resistant and FLU-susceptible C. albicans strains isolated from HIV positive patients with oropharyngeal candidiasis (OPC).Entities:
Keywords: Candida albicans; Essential oils; Fluconazole-resistant isolates; Oral candidiasis; Origanum vulgare
Year: 2016 PMID: 27222835 PMCID: PMC4877960
Source DB: PubMed Journal: Avicenna J Phytomed ISSN: 2228-7930
The compositions of some Iranian essential oils identified by gas chromatography/mass spectroscopy (GC-MS
|
|
|
|
|
|
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42% | Linalool | 63.40% | Thymol | 31.79% | Zingiberene | 27.87% | α-Pinene | 22.10% | α-Pinene |
| ||||||
| 25.10% | Thymol | 19% | ρ-Cymene | 15.88% | AR-Curcumene | 20.15% | 1,8-Cineole | 10.1% | Camphene |
| ||||||
| 10% | α-Terpineol | 16.90% | γ-Terpinene | 15.57% | β -Sesquiphellandrene | 10.26% | Linalool | 8.45% | Bisabolol oxide |
| ||||||
| 5.70% | Z-Caryohyllene | 0.40% | Sabinene | 9.29% | β -Bisabolene | 7.64% | α-Terpineol | 6.35% | α-Bisabolol |
| ||||||
| 3.40% | Borneol | 0.10% | β-Ocimene | 5.71% | α -Farnesene | 6.17% | Linalyl acetate | 5.64% | Limonene |
| ||||||
| 2.30% | Germanyl acetate | 0.07% | α-Thujene | 3.56% | γ -Cadinene | 4.87% | Germanyl acetate | 4% | Sabinene |
| ||||||
| 2% | 1,8-Cineole | 0.06% | α-Pinene | 3.23% | α -Eudesmol | 4.04% | α-Terpinyl acetate | 4% | Camphor |
| ||||||
| 1.70% | γ -Bisabolene | - | - | 2.35% | 4, 5-Dimethy1-11-Methylene Tricycle | 1.57% | Caryophyllene oxide | 3.45% | 1,8-Cineole |
| ||||||
| 1.60% | Camphor | - | - | 2.01% | Nerolidol | 1.57% | trans-Caryophyllene | 1.60% | α-Terpinene |
| ||||||
| 1.50% | Bicyclogermacrene | - | - | 2% | 7- α -(1-Hydroxyl-1-Methylethyl) | 1.48% | Methyl eugenol | 1% | γ-Terpinene |
| ||||||
| 1.30% | γ-Terpinene | - | - | 1.37% | Geraly acetate | 1.35% | α-Humulene | 0.90% | Germacrene D |
| ||||||
| 1% | Terpinen-4-ol | - | - | 1.10% | Germacrene B | 0.88% | β -Pinene | 0.89% | E-Sabinol |
| ||||||
| 0.50% | ρ-Cymene | - | - | 0.97% | Geraniol | 0.67% | 4-Terpineol | 0.87% | Z-Sabinenehydrate |
| ||||||
| 0.30% | α-Pinene | - | - | 0.97% | Endo- Borneol | 0.63% | δ-3-Carene | 0.85% | Bicyclogermacrene |
| ||||||
| 0.30% | Camphene | - | - | 0.93% | β -Phellandrene | 0.59% | γ-Terpinene | 0.76% | Spathulenol |
| ||||||
| - | - | - | - | 0.73% | Camphene | 0.54% | α-Thujene | 0.74% | 4-Terpineol |
| ||||||
| - | - | - | - | 0.64% | δ -Cadinene | 1.93% | Others | 0.68% | E-β-farnesene |
| ||||||
| - | - | - | - | - | - | - | - | 0.69% | α-Terpineol |
| ||||||
| - | - | - | - | - | - | - | - | 0.65% | Borneol |
| ||||||
| - | - | - | - | - | - | - | - | 0.65% | α-Funebrene |
| ||||||
| 5.12 | Others |
| ||||||||||||||
|
|
|
|
|
|
|
| - |
| - |
| ||||||
Minimal inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of some essential oils against Candida albicans isolates from HIV positive patients with oropharyngeal candidiasis
|
|
|
| ||
|---|---|---|---|---|
|
|
|
|
| |
|
| 320±44.72 | 420±44.72 | 320±44.72 | 400±70.71 |
|
| 3200±447.21 | 3800±570.08 | 3000±0 | 3600±223.60 |
|
| 2500±0 | 3000±0 | 2500±0 | 3100±223.60 |
|
| 1700±410.79 | 2300±273.86 | 1550±410.79 | 2200±273.86 |
|
| 300±0 | 400±0 | 300±0 | 400±0 |